Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

recombinant interleukin-2

Any recombinant analog of endogenous interleukin-2 (IL-2), a cytokine involved in intercellular communication related to cell differentiation, proliferation, inflammation, hematopoiesis, neuronal functions, and release of hormones. IL-2 binds to and activates specific receptors, triggering expression of specific genes, and may induce T cell-mediated tumor regression in some tumor types.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	human interleukin-2 interleukin II interleukin-2 lymphocyte mitogenic factor mitogenic factor T-cell growth factor TCGF thymocyte stimulating factor TSF
Abbreviation:	IL-2
Code name:	Ro-236019

recombinant interleukin-2

Search NCI's Drug Dictionary